RSV Vaccine Market Trends, Sales, Supply, Demand and Analysis by Forecast to 2035
The RSV vaccines landscape has transformed significantly since the approval of three RSV vaccines, namely Arexvy, Abrysvo and mRESVIA, since 2023. Ever since then, with the application of more advanced platforms to develop innovative vaccines, the life expectancy of patients with RSV diseases has risen remarkably.   The majority (46%) of the developers were established during the period...
0 Commentaires 0 Parts 127 Vue 0 Aperçu